Lung Cancer

The Food and Drug Administration will speed up its review of SNB-101 to treat patients with small cell lung cancer.

The Food and Drug Administration granted a Biologics License Application for subcutaneous Opdivo for potential approval.

All my life, I've been told that smoking leads to lung cancer. I never smoked, but I still got lung cancer.

From the death of author Paul Auster and musician Duane Eddy to King Charles’ visit to a cancer hospital, here’s what’s happening in the cancer space this week.

The oncolytic virus, MEM-288 will be studied in combination with Opdivo for patients with non-small cell lung cancer that progressed on standard therapy.

Alecensa was shown to reduce the risk of disease recurrence or death by 76% versus chemotherapy for patients with ALK-positive non-small cell lung cancer.

Before patients receive Enhertu for HER2-positive solid tumors, it’s important to know about the potential side effects.

Tecentriq plus Cabometyx conferred no overall survival benefit when compared with chemotherapy, a study showed.

Walt Disney died of lung cancer, leaving an important lesson to my son.

I wrote this heart-felt poem after watching my father pass away from stage 4 lung cancer.

I've found that nutrition and healthy foods play an important role during cancer.

Writing poetry helped me process the grief of losing my mom to metastatic lung cancer.

Some patients with limited-stage small cell lung cancer experienced overall survival benefits and progression-free survival via treatment with Imfinzi.

A clinical trial has started to evaluate the investigational drug MK-1084 and Keytruda among some patients with metastatic non-small cell lung cancer.

During cancer, we all share a common denominator: hope.

Since January 2024, the Food and Drug Administration has approved several treatments and combinations for solid tumors.

Dendritic cell maturation agent plinabulin, immunotherapy and chemotherapy are being studied in first-line extensive-stage small cell lung cancer.

Comprehensive biomarker testing and “timely” testing is “important” for patients with a specific lung cancer subset, an expert said.

Throughout my life, taking walks helped a lot with easing anxiety, so walking helped me when I received two diagnoses of cancer.

Certain patients with lung cancer who have EGFR exon 20 insertion mutations may have a new treatment option, which welcomes a new “milestone.”

As a three-time cancer survivor, I wonder: are my roots damaged or resting to find their way?

After having early-stage breast cancer and stage 3B lung cancer, I'm choosing to give back. Here's how.

The CURE® 2024 Lung Cancer Special Issue provides insight into the ever-changing innovation in the lung cancer space.

This special issue of CURE Lung Cancer takes a deeper dive into ALK-positive non-small cell lung cancer.

Patients with small cell lung cancer have reasons to be optimistic these days, as one expert explains to CURE.

What advancements for ALK-positive non-small cell lung cancer are on the way, from treating earlier stages of disease to postsurgical options?

The Food and Drug Administration approved Rybrevant plus carboplatin and pemetrexed for locally advanced or metastatic non-small cell lung cancer (NSCLC) that has EGFR exon 20 insertion mutations.

I agree that cancer is portrayed very stereotypically in society, so here are some ways I think we can highlight the reality of cancer.

After Tepmetko’s full approval for metastatic lung cancer treatment, patients should feel that the data from the accelerated approval is validated, an expert said.

The FDA granted a breakthrough therapy designation to BAY 2927088 after it showed promise in treating patients with HER2 mutations.